ArticleBMC pulmonary medicine2022

Clinical outcomes and risk factor of immune checkpoint inhibitors-related pneumonitis in non-small cell lung cancer patients with chronic obstructive pulmonary disease.

Zhu Zeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.